blood, plasma, COVID-19, SARS-CoV-2, pandemic, coronavirus, FDA, Food and Drug Administration, emergency use authorization, EUA, treatment
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical

White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.

White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.

plasma therapy

a bag of plasma ready to be delivered by IV
Doctors Forge Ahead with Plasma for COVID-19, Benefits Uncertain
Shawna Williams | Aug 14, 2020
Researchers say the popularity of convalescent plasma makes it more difficult to gather high-quality data on its efficacy.
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  
coronavirus covid-19 sars-cov-2 antibodies plasma therapy b cells monkey macaques
Monkeys Develop Protective Antibodies to SARS-CoV-2
Katarina Zimmer | Mar 17, 2020
A small study of macaques finds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19.